Patient Case Study - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

Patient Case Study

Description:

ECG S.R. QRS normal duration. Discharge Medication. Atorvastatin 80mg.o.d. ... One Month Later. NYHA II. No Peripheral Oedema. BP 106/70 HR 72 Wt 107kg ... – PowerPoint PPT presentation

Number of Views:176
Avg rating:3.0/5.0
Slides: 19
Provided by: bro7150
Category:
Tags: case | ecg | patient | study

less

Transcript and Presenter's Notes

Title: Patient Case Study


1
Patient Case Study
  • Julie Brown

2
P.M.H.
  • Prostate Cancer (2003)
  • P.T.E. (2004)
  • Hypercholesterolemia
  • Obesity

3
Admission May 2005.
  • Decompensated C.H.F.
  • ECHO severe LVSD. Mild MR.
  • ECG S.R. QRS normal duration.

4
Discharge Medication
  • Atorvastatin 80mg.o.d.
  • Warfarin 3mg.o.d.
  • Ramipril 5mg o.d.
  • Frusemide 120mg b.d.
  • UEs
  • Na 139
  • K 3.3
  • Urea 6.3
  • Creat 130

5
First Visit
  • NYHA III
  • Peripheral Oedema
  • Weight 109kg
  • BP 108/70 HR 94 S.R.
  • K 3.4 Urea 3.8 Creat 118.

6
Intervention/Action
  • Education
  • Add in Spironolactone 25mg o.d.(Following D/W
    Cardiologist).

7
Subsequent Home Visit
  • NYHA III(a little better)
  • Peripheral Oedema
  • Diarrhoea!!
  • BP 112/70 H.R.92 WT 108kg
  • K 3.6 Urea 5.7 Creat 121

8
Action
  • Stop Spironolactone .

9
Subsequent visit.
  • NYHA II
  • Weight loss 2kg
  • No peripheral oedema
  • Dry irritating Cough persists
  • K 4.0 Urea 5.3 Creat 118

10
Action
  • ? ACE Cough
  • Stop Ramipril
  • Commence Losartan (ARB) and titrate up to 100mg
    daily.

11
Subsequent Visit
  • NYHA II
  • No Peripheral Oedema
  • Cough settled
  • BP 110/78 HR 70 Wt 107KG

12
Action
  • Initiate Beta-Blocker.( Carvedilol 3.125mg b.d.)

13
Subsequent Clinic Visit
  • Carvedilol 25mg b.d.
  • NYHA II/III
  • Peripheral Oedema to mid calf
  • BP 100/66 HR 70 Wt 110kg
  • K 4.0 Urea 6.3 Creat 119

14
Action
  • Add in Bendroflumethiazide 2.5mg daily.

15
One Month Later
  • NYHA II
  • No Peripheral Oedema
  • BP 106/70 HR 72 Wt 107kg
  • Titrate Carvedilol up to Optimum level (50kg b.d.)

16
Subsequent Contact
  • NYHA II
  • C/O Light-headedness
  • Feels Thirsty
  • BP 90/60
  • K 3.9 Urea 13.9 Creat 135

17
Action
  • Reduce Bendoflumethiazide to 2.5mg on alternate
    days.

18
Current Status
  • NYHA II
  • Feels well
  • No peripheral oedema
  • On optimum anti failure medication
  • Bendroflumethiazide discontinued
  • On Frusemide 80 mg b.d.
  • Awaiting echo to assess LV function
  • Discharge to GP .
Write a Comment
User Comments (0)
About PowerShow.com